IL260043A - egf(a) analogues with fatty acid converters - Google Patents

egf(a) analogues with fatty acid converters

Info

Publication number: IL260043A
Authority: IL; Israel
Prior art keywords: egf; analogues; fatty acid; acid substituents; substituents
Prior art date: 2016-01-13

Application number

IL260043A

Other languages

English (en)

Hebrew (he)

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2016-01-13

Filing date

2018-06-14

Publication date

2018-07-31

2018-06-14 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

2018-07-31 Publication of IL260043A publication Critical patent/IL260043A/en

Links

125000005313 fatty acid group Chemical group 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Zoology (AREA)
Immunology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Cell Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)

IL260043A 2016-01-13 2018-06-14 egf(a) analogues with fatty acid converters IL260043A (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
CN2016070791		2016-01-13
CN2016076580		2016-03-17
EP16195965		2016-10-27
PCT/EP2017/050668 WO2017121850A1 (en)	2016-01-13	2017-01-13	Egf(a) analogues with fatty acid substituents

Publications (1)

Publication Number	Publication Date
IL260043A true IL260043A (en)	2018-07-31

Family

ID=57868232

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL260043A IL260043A (en)	2016-01-13	2018-06-14	egf(a) analogues with fatty acid converters

Country Status (26)

Country	Link
US (2)	US10822385B2 (2)
EP (1)	EP3402811B1 (2)
JP (2)	JP6797926B2 (2)
KR (1)	KR102417487B1 (2)
CN (1)	CN108473550B (2)
AU (1)	AU2017207862B2 (2)
BR (1)	BR112018013820A2 (2)
CA (1)	CA3010756A1 (2)
CL (1)	CL2018001868A1 (2)
CO (1)	CO2018007440A2 (2)
DK (1)	DK3402811T3 (2)
ES (1)	ES2916998T3 (2)
HR (1)	HRP20220720T1 (2)
HU (1)	HUE058647T2 (2)
IL (1)	IL260043A (2)
LT (1)	LT3402811T (2)
MX (1)	MX2018008681A (2)
MY (1)	MY195199A (2)
PE (1)	PE20181376A1 (2)
PH (1)	PH12018501502A1 (2)
PL (1)	PL3402811T3 (2)
RS (1)	RS63298B1 (2)
RU (1)	RU2747877C2 (2)
SA (1)	SA518391996B1 (2)
SI (1)	SI3402811T1 (2)
WO (1)	WO2017121850A1 (2)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI3402811T1 (sl)	2016-01-13	2022-06-30	Novo Nordisk A/S	Analogi EGF(A) z maščobnokislinskimi substituenti
SI3402782T1 (sl)	2016-01-13	2020-11-30	Grunenthal Gmbh	8-amino-2-okso-1,3-diaza-spiro-(4,5)-dekanski derivati
CA3011176C (en)	2016-01-13	2023-09-19	Grunenthal Gmbh	3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
CA3011180A1 (en)	2016-01-13	2017-07-20	Grunenthal Gmbh	3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
SI3402784T1 (sl)	2016-01-13	2020-07-31	Gruenenthal Gmbh	Derivati 3-((hetero)aril)-alkil-8-amino-2-okso-1,3-diaza-spiro-(4.5)-dekana
MA49617A (fr) *	2017-07-19	2020-05-27	Novo Nordisk As	Analogues d'egf(a), préparation, formulations et utilisations associées
CA3068956A1 (en)	2017-07-19	2019-01-24	Novo Nordisk A/S	Bifunctional compounds
US11358994B2 (en) *	2017-07-27	2022-06-14	Saint Louis University	Fatty acid modified human epidermal growth factor
IL279363B2 (en)	2018-06-21	2025-12-01	Merck Sharp & Dohme	Pcsk9 antagonist compounds
WO2020070276A1 (en)	2018-10-05	2020-04-09	Novo Nordisk A/S	Bifunctional compounds comprising insulin peptides and egf(a) peptides
CA3131997A1 (en)	2019-03-22	2020-10-01	3M Innovative Properties Company	Fall-protection system with monitoring system
CN110357969B (zh) *	2019-05-27	2022-03-08	北京志道生物科技有限公司	一种GLP1-EGFa异源二聚体蛋白、功能及方法
AU2020326265A1 (en)	2019-08-07	2022-02-03	Novo Nordisk A/S	Solid compositions comprising an EGF(A) derivative and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
CN114641275A (zh)	2019-11-07	2022-06-17	诺和诺德股份有限公司	包含pcsk9抑制剂和n-(8-(2-羟基苯甲酰基)氨基)辛酸的盐的固体组合物
EP4076492A4 (en)	2019-12-20	2024-01-17	Merck Sharp & Dohme LLC	PCSK9 ANTAGONIST COMPOUNDS
JP2024527488A (ja)	2021-07-02	2024-07-25	スリーエムイノベイティブプロパティズカンパニー	落下防止安全装置と連動される空中リフト
WO2023012263A1 (en)	2021-08-04	2023-02-09	Novo Nordisk A/S	Solid oral peptide formulations

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007022123A2 (en)	2005-08-11	2007-02-22	Amylin Pharmaceuticals, Inc.	Hybrid polypeptides with selectable properties
JP2009510999A (ja)	2005-07-29	2009-03-19	エーエムプロテインコーポレイション	キメラ治療剤
JP5721432B2 (ja)	2007-08-15	2015-05-20	ノボ・ノルデイスク・エー／エス	アミノ酸含有アルキレングリコール反復単位を含むアシル部を有するインスリン
MX2010011499A (es) *	2008-04-23	2010-11-12	Amgen Inc	Variantes de proproteina neutralizante de convertasa subtilisina kexina de tipo 9 (pcsk9) y sus usos.
WO2009143633A1 (en)	2008-05-30	2009-12-03	Institut De Recherches Cliniques De Montreal	Pcsk9 inhibitors and methods of use thereof
TWI516501B (zh) *	2008-09-12	2016-01-11	禮納特神經系統科學公司	Ｐｃｓｋ９拮抗劑類
CN101993485B (zh)	2009-08-20	2013-04-17	重庆富进生物医药有限公司	促胰岛素分泌肽类似物同源二聚体及其用途
CN103052900A (zh)	2010-08-02	2013-04-17	日本电气株式会社	偏振器和发光装置
CN102153652A (zh)	2010-12-10	2011-08-17	浙江大学	一种融合蛋白的表达方法及用途
JP2014510516A (ja)	2011-02-15	2014-05-01	ノヴォノルディスクアー／エス	長時間作用性ｉｌ−１受容体アンタゴニスト
WO2012177741A1 (en) *	2011-06-20	2012-12-27	Genentech, Inc.	Pcsk9-binding polypeptides and methods of use
AU2012311484B2 (en) *	2011-09-23	2017-04-13	Novo Nordisk A/S	Novel glucagon analogues
UY34347A (es)	2011-09-26	2013-04-30	Novartis Ag	Proteínas de función dual para tratar trastornos metabólicos
US20140357838A1 (en) *	2011-12-21	2014-12-04	Novo Nordisk A/S	N-Terminally Modified Insulin Derivatives
EP2851429B1 (en)	2012-05-18	2019-07-24	Adda Biotech Inc.	Protein and protein conjugate for diabetes treatment, and applications thereof
TW201420606A (zh)	2012-08-22	2014-06-01	Lilly Co Eli	同源二聚體蛋白
JP2015533483A (ja)	2012-09-07	2015-11-26	サノフイ	メタボリックシンドロームを治療するための融合タンパク質
EP2986313B1 (en) *	2013-04-18	2019-06-12	Novo Nordisk A/S	Stable, protracted glp-1/glucagon receptor co-agonists for medical use
EP3052521A1 (en)	2013-10-03	2016-08-10	Moderna Therapeutics, Inc.	Polynucleotides encoding low density lipoprotein receptor
CA2935285A1 (en)	2014-02-21	2015-08-27	Medimmune, Llc	Anti-pcsk9-glp-1 fusions and methods for use
US10570184B2 (en) *	2014-06-04	2020-02-25	Novo Nordisk A/S	GLP-1/glucagon receptor co-agonists for medical use
CN104558198A (zh)	2014-07-25	2015-04-29	成都贝爱特生物科技有限公司	GLP-1类似物和amylin类似物的融合蛋白制备及其用途
US20180207223A1 (en) *	2015-03-19	2018-07-26	Institut De Cardiologie De Montreal	Pcsk9 inhibitory polypolypeptides and methods of use
CN105367884A (zh)	2015-11-02	2016-03-02	陈薇	一种绝缘耐火抗辐射的屏蔽电缆材料及其制备方法
SI3402811T1 (sl)	2016-01-13	2022-06-30	Novo Nordisk A/S	Analogi EGF(A) z maščobnokislinskimi substituenti
CA3068956A1 (en)	2017-07-19	2019-01-24	Novo Nordisk A/S	Bifunctional compounds
MA49617A (fr)	2017-07-19	2020-05-27	Novo Nordisk As	Analogues d'egf(a), préparation, formulations et utilisations associées

2017
- 2017-01-13 SI SI201731149T patent/SI3402811T1/sl unknown
- 2017-01-13 US US16/069,932 patent/US10822385B2/en active Active
- 2017-01-13 RS RS20220538A patent/RS63298B1/sr unknown
- 2017-01-13 PE PE2018001257A patent/PE20181376A1/es unknown
- 2017-01-13 CA CA3010756A patent/CA3010756A1/en not_active Withdrawn
- 2017-01-13 PL PL17701078T patent/PL3402811T3/pl unknown
- 2017-01-13 LT LTEPPCT/EP2017/050668T patent/LT3402811T/lt unknown
- 2017-01-13 BR BR112018013820-7A patent/BR112018013820A2/pt not_active Application Discontinuation
- 2017-01-13 JP JP2018536444A patent/JP6797926B2/ja active Active
- 2017-01-13 DK DK17701078.2T patent/DK3402811T3/da active
- 2017-01-13 RU RU2018127882A patent/RU2747877C2/ru active
- 2017-01-13 MY MYPI2018702319A patent/MY195199A/en unknown
- 2017-01-13 HU HUE17701078A patent/HUE058647T2/hu unknown
- 2017-01-13 WO PCT/EP2017/050668 patent/WO2017121850A1/en not_active Ceased
- 2017-01-13 ES ES17701078T patent/ES2916998T3/es active Active
- 2017-01-13 MX MX2018008681A patent/MX2018008681A/es unknown
- 2017-01-13 KR KR1020187022105A patent/KR102417487B1/ko not_active Expired - Fee Related
- 2017-01-13 HR HRP20220720TT patent/HRP20220720T1/hr unknown
- 2017-01-13 EP EP17701078.2A patent/EP3402811B1/en active Active
- 2017-01-13 CN CN201780006783.6A patent/CN108473550B/zh active Active
- 2017-01-13 AU AU2017207862A patent/AU2017207862B2/en not_active Ceased
2018
- 2018-06-14 IL IL260043A patent/IL260043A/en unknown
- 2018-07-09 CL CL2018001868A patent/CL2018001868A1/es unknown
- 2018-07-10 SA SA518391996A patent/SA518391996B1/ar unknown
- 2018-07-12 PH PH12018501502A patent/PH12018501502A1/en unknown
- 2018-07-16 CO CONC2018/0007440A patent/CO2018007440A2/es unknown
2020
- 2020-09-17 US US17/024,264 patent/US20200407409A1/en not_active Abandoned
- 2020-11-17 JP JP2020190846A patent/JP2021035989A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
CN108473550A (zh)	2018-08-31
AU2017207862A1 (en)	2018-07-05
DK3402811T3 (da)	2022-06-13
US20200407409A1 (en)	2020-12-31
JP6797926B2 (ja)	2020-12-09
PE20181376A1 (es)	2018-09-05
WO2017121850A1 (en)	2017-07-20
PL3402811T3 (pl)	2022-07-11
EP3402811A1 (en)	2018-11-21
JP2019505521A (ja)	2019-02-28
EP3402811B1 (en)	2022-03-30
KR20180100177A (ko)	2018-09-07
RS63298B1 (sr)	2022-07-29
CN108473550B (zh)	2022-11-22
PH12018501502A1 (en)	2019-03-25
US10822385B2 (en)	2020-11-03
US20190016768A1 (en)	2019-01-17
MY195199A (en)	2023-01-11
KR102417487B1 (ko)	2022-07-06
CO2018007440A2 (es)	2018-09-28
RU2018127882A3 (2)	2020-06-19
RU2018127882A (ru)	2020-02-13
MX2018008681A (es)	2018-09-17
SI3402811T1 (sl)	2022-06-30
SA518391996B1 (ar)	2021-07-14
HRP20220720T1 (hr)	2022-09-30
LT3402811T (lt)	2022-06-10
ES2916998T3 (es)	2022-07-06
HUE058647T2 (hu)	2022-09-28
CA3010756A1 (en)	2017-07-20
BR112018013820A2 (pt)	2018-12-11
RU2747877C2 (ru)	2021-05-17
CL2018001868A1 (es)	2018-08-31
AU2017207862B2 (en)	2020-12-17
JP2021035989A (ja)	2021-03-04

Publication	Publication Date	Title
IL260043A (en)	2018-07-31	egf(a) analogues with fatty acid converters
HUS2500009I1 (hu)	2025-02-28	PTH prodrugok
IL265588A (en)	2019-05-30	Treprostinil prodrugs
GB202112537D0 (en)	2021-10-20	A connector arrangement
SG11201609333YA (en)	2016-12-29	A micellar nanocomplex
EP3090209A4 (en)	2017-01-04	A cooled grommet for a combustor wall assembly
GB201611674D0 (en)	2016-08-17	A turbine arrangement
GB2549510B (en)	2021-03-17	A Connector
LT3070231T (lt)	2021-02-25	Nuimama danga su užspaudžiama jungtimi
GB201420109D0 (en)	2014-12-24	A kite
ZA201607059B (en)	2018-11-28	Omega-3 analogues
GB201417701D0 (en)	2014-11-19	A kite
PL3280879T3 (pl)	2021-12-27	Układ do turbiny
EP3102980A4 (en)	2017-08-16	High-power ultra-short pulse fiber laser-illuminated projector
AU201615213S (en)	2016-10-04	A head board
GB201518909D0 (en)	2015-12-09	A formulation
PT3402811T (pt)	2022-06-23	Análogos de egf(a) com substituintes de ácidos gordos
HK1262866A1 (en)	2020-01-24	Egf(a) analogues with fatty acid substituents
LT3100836T (lt)	2020-02-10	Plokštės gamyba
IL243440A0 (en)	2016-02-29	Lollipop
GB201507081D0 (en)	2015-06-10	Nozzle tip manufacturing
HK40027675A (en)	2021-01-22	Acrylic acid analogs
EP3658527A4 (en)	2021-04-07	ACRYLIC ACID ANALOGUES
GB2558331B (en)	2021-09-08	A banner
PH32015000107S1 (en)	2015-03-13	Tummy portion of a jeans (x-stitch)